Sign In
Buy INM
$1.50
+0.0100 (+0.671%)
At Close: Jun 22, 2026
Inmed Pharmaceuticals Earnings Calls
Mar 31, 2026
-$0.690 (99.27%)
| Release date | May 06, 2026 |
| EPS estimate | -$94.44 |
| EPS actual | -$0.690 |
| EPS Surprise | 99.27% |
| Revenue estimate | 659.848M |
| Revenue actual | 1.262M |
| Revenue Surprise | -99.81% |
Dec 31, 2025
| Release date | Feb 11, 2026 |
| EPS estimate | - |
| EPS actual | -$0.510 |
| Revenue estimate | - |
| Revenue actual | 1.112M |
Sep 30, 2025
| Release date | Nov 06, 2025 |
| EPS estimate | - |
| EPS actual | -$0.440 |
| Revenue estimate | - |
| Revenue actual | 1.12M |
Jun 30, 2025
| Release date | Sep 23, 2025 |
| EPS estimate | - |
| EPS actual | -$3.80 |
| Revenue estimate | - |
| Revenue actual | 1.777M |
Last 4 Quarters for Inmed Pharmaceuticals
Below you can see how INM performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Jun 30, 2025
| Release date | Sep 23, 2025 |
| Price on release | $2.14 |
| EPS estimate | - |
| EPS actual | -$3.80 |
| Date | Price |
|---|---|
| Sep 17, 2025 | $2.36 |
| Sep 18, 2025 | $2.36 |
| Sep 19, 2025 | $2.29 |
| Sep 22, 2025 | $2.27 |
| Sep 23, 2025 | $2.14 |
| Sep 24, 2025 | $2.18 |
| Sep 25, 2025 | $2.18 |
| Sep 26, 2025 | $2.19 |
| Sep 29, 2025 | $2.27 |
| 4 days before | -9.32% |
| 4 days after | 6.07% |
| On release day | 1.87% |
| Change in period | -3.81% |
Sep 30, 2025
| Release date | Nov 06, 2025 |
| Price on release | $1.71 |
| EPS estimate | - |
| EPS actual | -$0.440 |
| Date | Price |
|---|---|
| Oct 31, 2025 | $1.88 |
| Nov 03, 2025 | $1.85 |
| Nov 04, 2025 | $1.73 |
| Nov 05, 2025 | $1.73 |
| Nov 06, 2025 | $1.71 |
| Nov 07, 2025 | $1.60 |
| Nov 10, 2025 | $1.62 |
| Nov 11, 2025 | $1.74 |
| Nov 12, 2025 | $1.73 |
| 4 days before | -9.31% |
| 4 days after | 1.47% |
| On release day | -6.16% |
| Change in period | -7.98% |
Dec 31, 2025
| Release date | Feb 11, 2026 |
| Price on release | $0.99 |
| EPS estimate | - |
| EPS actual | -$0.510 |
| Date | Price |
|---|---|
| Feb 05, 2026 | $1.01 |
| Feb 06, 2026 | $0.94 |
| Feb 09, 2026 | $0.94 |
| Feb 10, 2026 | $1.00 |
| Feb 11, 2026 | $0.99 |
| Feb 12, 2026 | $0.89 |
| Feb 13, 2026 | $0.88 |
| Feb 17, 2026 | $0.85 |
| Feb 18, 2026 | $0.86 |
| 4 days before | -1.98% |
| 4 days after | -13.23% |
| On release day | -10.09% |
| Change in period | -14.95% |
Mar 31, 2026
Beat
| Release date | May 06, 2026 |
| Price on release | $0.726 |
| EPS estimate | -$94.44 |
| EPS actual | -$0.690 |
| EPS surprise | 99.27% |
| Date | Price |
|---|---|
| Apr 30, 2026 | $0.720 |
| May 01, 2026 | $0.715 |
| May 04, 2026 | $0.748 |
| May 05, 2026 | $0.740 |
| May 06, 2026 | $0.726 |
| May 07, 2026 | $0.696 |
| May 08, 2026 | $0.650 |
| May 11, 2026 | $0.621 |
| May 12, 2026 | $0.655 |
| 4 days before | 0.89% |
| 4 days after | -9.83% |
| On release day | -4.13% |
| Change in period | -9.03% |
Inmed Pharmaceuticals Earnings History
Earnings Calendar
FAQ
When is the earnings report for INM?
Inmed Pharmaceuticals Inc. (INM) has scheduled its earnings report for Sep 18, 2026 after the markets close.
What is the INM price-to-earnings (P/E) ratio?
INM P/E ratio as of Jun 22, 2026 (TTM) is -0.609.
What is the INM EPS forecast?
The forecasted EPS (Earnings Per Share) for Inmed Pharmaceuticals Inc. (INM) for the first fiscal quarter 2026 is -$94.44.
What are Inmed Pharmaceuticals Inc.'s retained earnings?
On its balance sheet, Inmed Pharmaceuticals Inc. reported retained earnings of $1.26 million for the latest quarter ending Mar 31, 2026.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
